文献速递临床试验与 GCP基础与转化研究

远程缺血预适应对急诊髋部骨折手术心肌损伤的影响(PIXIE试验):II期随机临床试验

The effect of remote ischaemic preconditioning on myocardial injury in emergency hip fracture surgery (PIXIE trial): phase II randomised clinical trial.
PubMed 文献 · BMJ · 2019-12-04

PIXIE试验是一项多中心、随机、观察者盲法的II期临床试验,纳入648例有心血管危险因素的髋部骨折手术患者,评估远程缺血预适应(RIPC)对术后心肌损伤的影响。结果显示RIPC组主要结局(术后4天内肌钙蛋白I峰值≥45 ng/L)发生率显著低于对照组(15% vs 28%,OR 0.44,95%CI 0.25-0.76,P=0.003),修订主要结局(OR 0.55,95%CI 0.37-0.80,P=0.002)和心肌梗死(OR 0.46,95%CI 0.21-0.99,P=0.04)也显著降低。但其他临床次要结局的统计效能不足,无法得出确切结论。

要点

  • RIPC可降低急诊髋部骨折手术后心肌损伤风险(OR 0.44,95%CI 0.25-0.76)。
  • RIPC组心肌梗死发生率低于对照组(3% vs 7%,OR 0.46,95%CI 0.21-0.99)。
  • RIPC对主要不良心血管事件和30天死亡率的影响尚不能确定。

核心结论

  • RIPC降低了急诊髋部骨折手术后心肌损伤和心肌梗死的风险。
  • 不能得出RIPC总体上预防术后主要不良心血管事件的结论。
  • 研究结果支持开展更大规模临床试验以评估长期临床结局和死亡率。

研究设计与样本

  • 共纳入648例有心血管危险因素且接受髋部骨折手术的患者,286例分配至RIPC组,287例分配至标准实践对照组。
  • RIPC操作在术前开始,使用止血带于上臂进行四个循环的前臂缺血5分钟再灌注5分钟。
  • 主要结局为术后4天内发生心肌损伤,定义为缺血导致的血浆心肌肌钙蛋白I峰值浓度≥45 ng/L;修订主要结局为肌钙蛋白I峰值≥45 ng/L或高敏肌钙蛋白I>24 ng/L。

主要发现

  • 意向性治疗分析纳入573例患者(平均年龄79岁,标准差10;女性399例,占70%)。
  • 主要结局在RIPC组168例中发生25例(15%),对照组158例中发生45例(28%),OR 0.44(95%CI 0.25-0.76),P=0.003。
  • 修订主要结局在RIPC组286例中发生57例(20%),对照组287例中发生90例(31%),OR 0.55(95%CI 0.37-0.80),P=0.002。
  • 心肌梗死发生在RIPC组10例(3%),对照组21例(7%),OR 0.46(95%CI 0.21-0.99),P=0.04。
  • 其他临床次要结局(主要不良心血管事件、30天全因死亡率、术后住院时间、ICU住院时间)的统计效能不足,无法得出确切结论。

关键数值与推荐

  • 主要结局:术后4天内缺血导致的肌钙蛋白I峰值≥45 ng/L。
  • 修订主要结局:术后4天内肌钙蛋白I峰值≥45 ng/L或高敏肌钙蛋白I>24 ng/L。
  • RIPC操作:上臂止血带,四个循环的前臂缺血5分钟再灌注5分钟。

临床怎么用

  • 对于有心血管危险因素的急诊髋部骨折手术患者,可考虑术前实施RIPC以降低围术期心肌损伤风险。
  • RIPC操作简单,使用上臂止血带进行四个循环的缺血再灌注即可。
  • 需注意RIPC对主要不良心血管事件和死亡率的长期影响尚不明确,应个体化评估。

局限性

  • II期试验设计,样本量不足以对其他临床次要结局(如主要不良心血管事件、30天死亡率)得出确切结论。
  • 主要结局因检测方法可用性而修订,可能影响结果解释。
  • 仅纳入丹麦三家大学医院的患者,外推性需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether remote ischaemic preconditioning (RIPC) prevents myocardial injury in patients undergoing hip fracture surgery. DESIGN: Phase II, multicentre, randomised, observer blinded, clinical trial. SETTING: Three Danish university hospitals, 2015-17. PARTICIPANTS: 648 patients with cardiovascular risk factors undergoing hip fracture surgery. 286 patients were assigned to RIPC and 287 were assigned to standard practice (control group). INTERVENTION: The RIPC procedure was initiated before surgery with a tourniquet applied to the upper arm and consisted of four cycles of forearm ischaemia for five minutes followed by reperfusion for five minutes. MAIN OUTCOME MEASURES: The original primary outcome was myocardial injury within four days of surgery, defined as a peak plasma cardiac troponin I concentration of 45 ng/L or more caused by ischaemia. The revised primary outcome was myocardial injury within four days of surgery, defined as a peak plasma cardiac troponin I concentration of 45 ng/L or more or high sensitive troponin I greater than 24 ng/L (the primary outcome was changed owing to availability of testing). Secondary outcomes were peak plasma troponin I and total troponin I release during the first four days after surgery (cardiac and high sensitive troponin I), perioperative myocardial infarction, major adverse cardiovascular events, and all cause mortality within 30 days of surgery, length of postoperative stay, and length of stay in the intensive care unit. Several planned secondary outcomes will be reported elsewhere. RESULTS: 573 of the 648 randomised patients were included in the intention-to-treat analysis (mean age 79 (SD 10) years; 399 (70%) women). The primary outcome occurred in 25 of 168 (15%) patients in the RIPC group and 45 of 158 (28%) in the control group (odds ratio 0.44, 95% confidence interval 0.25 to 0.76; P=0.003). The revised primary outcome occurred in 57 of 286 patients (20%) in the RIPC group and 90 of 287 (31%) in the control group (0.55, 0.37 to 0.80; P=0.002). Myocardial infarction occurred in 10 patients (3%) in the RIPC group and 21 patients (7%) in the control group (0.46, 0.21 to 0.99; P=0.04). Statistical power was insufficient to draw firm conclusions on differences between groups for the other clinical secondary outcomes (major adverse cardiovascular events, 30 day all cause mortality, length of postoperative stay, and length of stay in the intensive care unit). CONCLUSIONS: RIPC reduced the risk of myocardial injury and infarction after emergency hip fracture surgery. It cannot be concluded that RIPC overall prevents major adverse cardiovascular events after surgery. The findings support larger scale clinical trials to assess longer term clinical outcomes and mortality. TRIAL REGISTRATION: ClinicalTrials.gov NCT02344797.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Ekeloef S, Homilius M, Stilling M, et al. The effect of remote ischaemic preconditioning on myocardial injury in emergency hip fracture surgery (PIXIE trial): phase II randomised clinical trial. BMJ. 2019. PMID: 31801725. doi:10.1136/bmj.l6395

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。